Relypsa (RLYP) volatility elevated ahead of FDA decision on AstraZeneca (AZN) competing drug

May 27, 2016 6:04 AM

Relypsa (NASDAQ: RLYP) June weekly call option implied volatility ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found